These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31715006)

  • 21. The NCDR Left Atrial Appendage Occlusion Registry.
    Freeman JV; Varosy P; Price MJ; Slotwiner D; Kusumoto FM; Rammohan C; Kavinsky CJ; Turi ZG; Akar J; Koutras C; Curtis JP; Masoudi FA
    J Am Coll Cardiol; 2020 Apr; 75(13):1503-1518. PubMed ID: 32238316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-Year Outcomes and Cardiac Remodeling Following Left Atrial Appendage Occlusion.
    Liu B; Luo J; Gong M; Li Z; Shi B; Zhang X; Han X; Wei Y
    Clin Interv Aging; 2021; 16():655-663. PubMed ID: 33907387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence.
    Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D
    J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries.
    Wang W; Chen LY; Walker RF; Alonso A; Norby FL; Lakshminarayan K; Lutsey PL
    Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5786. PubMed ID: 38565524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of successful left atrial appendage occlusion with focus on stroke prevention: 10-year follow-up of a single-center registry.
    Maarse M; Aarnink EW; Huijboom MFM; Abeln BGS; Staal D; Rensing BJWM; Kerklaan JP; van Dijk VF; Swaans MJ; Boersma LVA
    Heart Rhythm O2; 2023 May; 4(5):298-308. PubMed ID: 37323993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　- First Results From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Ootomo T; Takayama M; Ando K; Hirao K; Morino Y; Hayashida K; Kusano K; Main ML; Saito S
    Circ J; 2018 Nov; 82(12):2946-2953. PubMed ID: 30305484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Decision Analysis of Percutaneous Left Atrial Appendage Occlusion Relative to Novel and Traditional Oral Anticoagulation for Stroke Prevention in Patients with New-Onset Atrial Fibrillation.
    Micieli A; Wijeysundera HC; Qiu F; Atzema CL; Singh SM
    Med Decis Making; 2016 Apr; 36(3):366-74. PubMed ID: 26139448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry.
    Hara H; Kubo S; Nakajima Y; Matsumoto T; Kondo Y; Sugane H; Okubo K; Nakagawa K; Nagatomo D; Hachinohe D; Kusa S; Goya M; Nanasato M; Arita T; Yamasaki H; Kuwabara K; Yoshiyama T; Tanaka N; Masuda M; Sakamoto T; Nakashima M; Ohno Y; Saito S; Fukunaga M
    J Cardiol; 2024 May; 83(5):298-305. PubMed ID: 37802202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or gastrointestinal bleeding: Insights from the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry.
    Gallo F; Ronco F; D'Amico G; Della Rocca DG; Mazzone P; Bordignon S; Casu G; Giannini F; Berti S; Horton RP; D'Angelo G; Urbanek L; Merella P; Ruggiero R; Romeo MR; Bosica F; Schmidt B; Atzori E; Barbierato M; Natale A; Themistoclakis S
    Catheter Cardiovasc Interv; 2023 May; 101(6):1144-1153. PubMed ID: 36924020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug.
    Santoro G; Meucci F; Stolcova M; Rezzaghi M; Mori F; Palmieri C; Paradossi U; Pastormerlo LE; Rosso G; Berti S
    EuroIntervention; 2016 Feb; 11(10):1188-94. PubMed ID: 25354761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left atrial appendage occlusion in patients older than 85 years. Safety and efficacy in the EWOLUTION registry.
    Cruz-González I; Ince H; Kische S; Schmitz T; Schmidt B; Gori T; Foley D; de Potter T; Tschishow W; Vireca E; Stein K; Boersma LV
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):21-27. PubMed ID: 30956034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk.
    Brockmeyer M; Wolff G; Krieger T; Lin Y; Karathanos A; Afzal S; Zeus T; Westenfeld R; Polzin A; Heinen Y; Perings S; Kelm M; Schulze V
    Acta Cardiol; 2020 Aug; 75(4):312-320. PubMed ID: 30983505
    [No Abstract]   [Full Text] [Related]  

  • 35. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periprocedural Outcomes Associated With Use of a Left Atrial Appendage Occlusion Device in China.
    Su F; Gao C; Liu J; Ning Z; He B; Liu Y; Xu Y; Yang B; Li Y; Zhang J; Zhao X; Zhang Y; Hu H; Du X; Xie R; Zhou L; Zeng J; Ruan Z; Liu H; Guo J; Wang R; Garg S; Soliman O; Holmes DR; Serruys PW; Tao L
    JAMA Netw Open; 2022 May; 5(5):e2214594. PubMed ID: 35639378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation.
    Noseworthy PA; Van Houten HK; Krumholz HM; Kent DM; Abraham NS; Graff-Radford J; Alkhouli M; Henk HJ; Shah ND; Gersh BJ; Friedman PA; Holmes DR; Yao X
    J Am Heart Assoc; 2022 Oct; 11(19):e027001. PubMed ID: 36172961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison between stand-alone left atrial appendage occlusion and resection as a method of preventing cardiogenic thromboembolic stroke.
    Yoshimoto A; Suematsu Y; Kurahashi K; Takahashi H; Inoue T
    Gen Thorac Cardiovasc Surg; 2024 Mar; 72(3):157-163. PubMed ID: 37468825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
    Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
    Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.